Spi-1/PU.1 Is a Positive Regulator of the Fli-1 Gene Involved in Inhibition of Erythroid Differentiation in Friend Erythroleukemic Cell Lines

REFERENCES

• Barbeau, B., D. Bergeron, M. Beaulieu, Z. Nadjem, and J. Rassart 1996. Characterization of the human and mouse Fli-1 promoter regions. Biochem. Biophys. Acta 1307:220–232.
   PubMedGoogle Scholar
• Bègue, A., P. Crépieux, N. Vu-Dac, A. Hauteville, N. Spruyt, V. Laudet, and J. Stehelin 1997. Identification of a second promoter in the human c-ets-2 proto-oncogene. Gene Expr. 6:333–347.
   PubMedGoogle Scholar
• Ben-David, Y., E. B. Giddens, and J. Bernstein 1990. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc. Natl. Acad. Sci. USA 87:1332–1336.
   PubMed Web of Science ®Google Scholar
• Ben-David, Y., E. R. Giddens, K. Letwin, and J. Bernstein 1991. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets family, Fli-1, closely linked to c-ets-1. Genes Dev. 5:908–919.
   PubMed Web of Science ®Google Scholar
• Ben-David, Y., and J. Bernstein 1991. Friend virus induced erythroleukemia and the multi stage of cancer. Cell 66:831–834.
   PubMed Web of Science ®Google Scholar
• Casadevall, N., C. Lacombe, O. Muller, S. Gisselbrecht, and J. Mayeux 1991. Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells (Friend cells): cross-linking of erythropoietin with the spleen focus-forming virus envelope protein. J. Biol. Chem. 266:16015–16020.
   PubMedGoogle Scholar
• Chen, H. M., D. Ray-Gallet, P. Zhang, C. J. Hetherington, D. A. Gonzales, D. E. Zhang, F. Moreau-Gachelin, and J. Tenen 1995. PU.1 (Spi-1) autoregulates its expression in myeloid cells. Oncogene 11:1549–1560.
   PubMed Web of Science ®Google Scholar
• Crépieux, P., D. Leprince, A. Flourens, O. Albagli, and J. Stehelin 1993. The two functionally distinct N termini of chicken c-ets-1 products arise from alternative promoters usage. Gene Expr. 3:215–225.
   PubMedGoogle Scholar
• Darby, T. G., J. D. Meibner, A. Rühlmann, W. H. Mueller, and J. Scheibe 1997. Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1. Oncogene 15:3067–3082.
   PubMedGoogle Scholar
• Delgado, M. D., M. Hallier, P. Meneceur, A. Tavitian, and J. Moreau-Gachelin 1994. Inhibition of Friend cells proliferation by Spi-1 antisense oligodeoxynucleotides. Oncogene 9:1723–1727.
   PubMedGoogle Scholar
• Doubeikovski, A., G. Uzan, Z. Doubeikovski, M. H. Prandini, F. Porteu, S. Gisselbrecht, and J. Dusanter-Fourt 1997. Thrombopoietin-induced expression of glycoprotein IIb gene involves the transcription factor PU-1/Spi-1 in UT7-Mpl cells. J. Biol. Chem. 272:24300–24307.
   PubMedGoogle Scholar
• Edamatsu, H., Y. Kaziro, and J. Itoh 1997. Inducible high-level expression vector for mammalian cells, pEF-LAC carrying human elongation factor 1α promoter and lac operator. Gene 187:289–294.
   PubMedGoogle Scholar
• Feinberg, A. P., and J. Vogelstein 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6–13.
   PubMed Web of Science ®Google Scholar
• Fisher, R. C., and J. Scott 1998. Role of PU.1 in hematopoiesis. Stem Cell 16:25–37.
   PubMed Web of Science ®Google Scholar
• Galson, D. L., J. O. Hensold, T. R. Bishop, M. Schalling, A. D. D’Andrea, C. Jones, P. E. Hauron, and J. Housman 1993. Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis. Mol. Cell. Biol. 13:2929–2941.
   PubMedGoogle Scholar
• Gauthier, J. M., B. Bourachot, V. Doucas, M. Yaniv, and J. Moreau-Gachelin 1993. Functional interference between the Spi-1/PU.1 oncoprotein and steroid hormone or vitamin receptors. EMBO J. 12:5089–5096.
   PubMedGoogle Scholar
• Grignani, F., L. Lombardi, G. Inghirami, L. Sternas, K. Cechova, and J. Dalla-Favera 1990. Negative autoregulation of c-myc gene expression is inactivated in transformed cells. EMBO J. 9:3913–3922.
   PubMed Web of Science ®Google Scholar
• Gubler, U., and J. Hoffmann 1983. A simple and very efficient method for generating cDNA libraries. Gene 25:263–269.
   PubMed Web of Science ®Google Scholar
• Hallier, M., A. Tavitian, and J. Moreau-Gachelin 1996. The transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrb. J. Biol. Chem. 271:11177–11181.
   PubMedGoogle Scholar
• Hallier, M., A. Lergan, S. Barnache, A. Tavitian, and J. Moreau-Gachelin 1998. The transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLS. J. Biol. Chem. 273:4838–4842.
   PubMed Web of Science ®Google Scholar
• Hensold, J. O., C. A. Stratton, D. Barth, and J. Galson 1996. Expression of the transcription factor, Spi-1 (PU.1), in differentiating murine erythroleukemia cells is regulated post-transcriptionally. Evidence for differential stability of transcription factor mRNAs following inducer exposure. J. Biol. Chem. 271:3385–3391.
   PubMedGoogle Scholar
• Howard, J. C., S. Yousefi, G. Cheong, A. Bernstein, and J. Ben-David 1993. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during erythroleukemias induced by F-MuLV. Oncogene 8:2721–2729.
   PubMedGoogle Scholar
• Howard, J. C., L. Berger, R. Bani, R. G. Hawley, and J. Ben-David 1996. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity. Oncogene 12:1405–1415.
   PubMedGoogle Scholar
• Hromas, R., A. Orazi, R. S. Neiman, R. Maki, C. Van Beveran, J. Moore, and J. Klemz 1993. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood 82:2998–3004.
   PubMed Web of Science ®Google Scholar
• Jonsen, M. D., J. M. Petersen, Q. P. Xu, and J. Graves 1996. Characterization of cooperative function of inhibitory sequences in Ets-1. Mol. Cell. Biol. 16:2065–2073.
   PubMed Web of Science ®Google Scholar
• Keller, G., M. Kennedy, T. Papayannopoulou, and J. Wiles 1993. Hematopoietic commitment during embryonic stem cell differentiation in culture. Mol. Cell. Biol. 13:473–486.
   PubMed Web of Science ®Google Scholar
• Klemsz, M. J., S. R. McKercher, A. Kaleda, C. Van Baveran, and J. Maki 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61:113–124.
   PubMed Web of Science ®Google Scholar
• Lane, D., and J. Benchimol 1990. p53: oncogene or antioncogene? Genes Dev. 4:1–8.
   PubMed Web of Science ®Google Scholar
• Li, J. P., A. D’Andrea, H. F. Lodish, and J. Baltimore 1990. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature (London) 343:762–764.
   PubMed Web of Science ®Google Scholar
• Mager, A. M., A. Grapin-Botton, K. Ladjali, D. Meyer, C. M. Wolff, P. Stiegler, M. A. Bonnin, and J. Remy 1998. The avian Fli gene is specifically expressed during embryogenesis in a subset of neural crest cells giving rise to mesenchyme. Int. J. Dev. Biol. 42:561–572.
   PubMedGoogle Scholar
• McKercher, S., B. Torbett, K. L. Anderson, G. W. Henkel, D. J. Vestal, H. Baribault, M. Klemsz, A. J. Feeney, G. E. Wu, C. J. Paige, and J. Maki 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:5647–5668.
   PubMed Web of Science ®Google Scholar
• Mélet, F., B. Motro, D. J. Rossi, L. Zhang, and J. Bernstein 1996. Generation of a novel Fli-1 protein by gene targeting leads to a defect in thymus development and a delay in Friend virus-induced erythroleukemia. Mol. Cell. Biol. 16:2708–2718.
   PubMed Web of Science ®Google Scholar
• Moreau-Gachelin, F., A. Tavitian, and J. Tambourin 1988. Spi-1 is a putative oncogene in virally induced murine erythroleukemia. Nature (London) 331:277–280.
   PubMed Web of Science ®Google Scholar
• Moreau-Gachelin, F., D. Ray, M. G. Mattei, P. Tambourin, and J. Tavitian 1989. The putative oncogene Spi-1: murine chromosomal localization and transcriptional activation in murine acute erythroleukemias. Oncogene 4:1449–1456.
   PubMedGoogle Scholar
• Moreau-Gachelin, F. 1994. Spi-1/PU.1: an oncogene of the ETS family. Biochim. Biophys. Acta 1198:149–163.
   PubMed Web of Science ®Google Scholar
• Moreau-Gachelin, F., F. Wendling, T. Molina, N. Denis, M. Titeux, G. Grimber, P. Briand, W. Vainchenker, and J. Tavitian 1996. Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol. Cell. Biol. 16:2453–2463.
   PubMed Web of Science ®Google Scholar
• Paul, R., S. Schuetze, S. L. Kozak, and J. Kabat 1989. A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization. J. Virol. 63:4958–4961.
   PubMedGoogle Scholar
• Quang, C. T., O. Wessely, M. Piroin, H. Beug, and J. Ghysdael 1997. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their kit ligand-dependent proliferation. EMBO J. 16:5639–5653.
   PubMedGoogle Scholar
• Rao, G., N. Rekhtman, G. Cheng, T. Krasikov, and J. Skoultchi 1997. Deregulated expression of the PU-1 transcription factor blocks murine erythroleukemia cell terminal differentiation. Oncogene 14:123–131.
   PubMedGoogle Scholar
• Ray-Gallet, D., C. Mao, A. Tavitian, and J. Moreau-Gachelin 1995. DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene 11:303–313.
   PubMedGoogle Scholar
• Sambrook, J., E. F. Fritsch, T. Maniatis 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Schuetze, S., P. E. Stenberg, and J. Kabat 1993. The ETS-related transcription factor PU.1 immortalizes erythroblasts. Mol. Cell. Biol. 13:5670–5678.
   PubMedGoogle Scholar
• Schuetze, S., R. Paul, B. C. Gliniak, and J. Kabat 1992. Role of the PU.1 transcription factor in controlling differentiation of Friend erythroleukemia cells. Mol. Cell. Biol. 12:2967–2975.
   PubMedGoogle Scholar
• Scott, E. W., M. C. Simon, J. Anastasi, and J. Singh 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573–1577.
   PubMed Web of Science ®Google Scholar
• Scott, E. W., R. C. Fisher, M. C. Olson, E. W. Kerli, M. C. Simon, and J. Singh 1997. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity 6:437–447.
   PubMed Web of Science ®Google Scholar
• Shivdasani, R. A., Y. Fujiwara, M. A. McDevitt, and J. Orkin 1997. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet differentiation. EMBO J. 16:3965–3973.
   PubMed Web of Science ®Google Scholar
• Skoda, R. C., S. F. Tsai, S. Orkin, and J. Leder 1995. Expression of c-myc under the control of GATA-1 regulatory sequences causes erythroleukemia in transgenic mice. J. Exp. Med. 181:1603–1613.
   PubMedGoogle Scholar
• Wasylyk, B., S. L. Hahn, and J. Giovane 1993. The ETS family of transcription factors. Eur. J. Biochem. 211:7–11.
   PubMedGoogle Scholar
• Yamada, T., N. Kondoh, M. Matsumoto, M. Yoshida, A. Maekawa, and J. Oikawa 1997. Overexpression of PU.1 induces growth and differentiation inhibition and apoptotic cell death in murine erythroleukemia cells. Blood 89:1383–1393.
   PubMedGoogle Scholar
• Yi, H. K., Y. Fujimara, M. Ouchida, D. D. K. Prasad, V. N. Rao, and J. Reddy 1997. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias. Oncogene 14:1259–1268.
   PubMed Web of Science ®Google Scholar
• Zhang, L., V. Lemarchandel, P. H. Roméo, Y. Ben-David, P. Greer, and J. Bernstein 1993. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing’s sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other ETS family members. Oncogene 8:1621–1630.
   PubMedGoogle Scholar
• Zhang, L., A. Eddy, Y. T. Teng, M. Fritzler, M. Kluppel, F. Mélet, and J. Bernstein 1995. An immunological renal disease in transgenic mice that overexpress Fli-1, a member of the ets family of transcription factor genes. Mol. Cell. Biol. 15:6961–6970.
   PubMed Web of Science ®Google Scholar